BenevolentAI
benevolent a validated approach internal pipeline validation strategic validation clinical regulatory validation pipeline generated from the benevolent platform one asset in phase assets in and named platform generated drug programmes exploratory stage programmes successful delivery on target long term collaboration us drug approved the benevolent successfully discovered an approved treatment for covid chronic kidney disease disease agnostic idiopathic pulmonary heart failure systemic lupus | BenevolentAI
Company
Deck Type
Sector
Industry
Deck date
September 2022
Slide
22 of 74
Related slides by other companies
Certara
Investor Day
December 2021
drug approvals using | Certara
MindMed
Investor Presentation
April 2021
most diversified pipeline of drugs in clinical development and experiential | MindMed
MindMed
Investor Presentation
June 2023
digital pipeline progression aligns with drug development | MindMed
Immix Biopharma
Investor Presentation
March 2024
pipeline only car in amyloidosis tailor made for indications | Immix Biopharma
Other recent decks by BenevolentAI
See all presentations (10 decks)
Results
March 2024
Investor Conference
January 2024
Investor Presentation
May 2023
Results
March 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io